Market Overview

Novavax Shares Up 0.5%; Wedbush Issues Mid-Day Note Reiterating Outperform Rating, $14 Target, Says 'Thinking about Pivotal RSV Data Coming This Quarter'

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for NVAX

DateFirmActionFromTo
Dec 2016Cantor FitzgeraldInitiates Coverage OnNeutral
Sep 2016Chardan CapitalMaintainsNeutral
Sep 2016CitigroupMaintainsNeutral

View More Analyst Ratings for NVAX
View the Latest Analyst Ratings

Posted-In: Analyst Color Price Target Reiteration Analyst Ratings

 

Related Articles (NVAX)